30 CA 19-9 Strips:\n Wels Reagents\n1 Sample well.\n2-3-4 Empty wells.\n5 Conjugate: Alkaline phosphatase labeled 1116-NS-19-9 antibody +\n0.9 g/l sodium azide (400 μl)\n6-7 Wash buffer: Tris (0.05 mol/l, pH 7.4) + 0.9 g/l sodium azide \n(600 μl).\n8 Diluent: Potassium phosphate (0.05 mol/l) + 0.9 g/l sodium azide \n(400 μl).\n9 Wash buffer: Tris (0.05 mol/l, pH 7.4) + 0.9 g/l sodium azide \n(600 μl).\n10 Cuvette with substrate: 4-Methyl-umbelliferyl-phosphate (0.6 mmol/l) + diethanolamine (DEA) (0.62 mol/l or 6.6%, pH 9.2) + 1 g/l sodium azide (300 μl). \n\n30 CA 19-9 SPRs:\ninterior of SPRs coated with mouse monoclonal 1116-NS-19-9 antibodies.\n\nCA 19-9 control:\nBovine albumin + 1116-NS-19-9 reactive antigentic determinants (human origin) + 0.9 g/l sodium azide.\n\nCA 19-9 calibrator:\nBovine albumin + 1116-NS-19-9 reactive antigentic determinants (human origin) + 0.9 g/l sodium azide.\n\nCA 19-9 diluent:\nHuman serum + 1 g/l sodium azide.\n\nMLE c

共有 1 個藥物證書使用此成份

申請商
香港商生物梅里埃有限公司台灣分公司 
適應症
含量
發證日期
2006-01-05